In the News!

50% Imaging Error Rate in Clinical Trials Discussed by Expert Panelists from 5 NCI-Designated Cancer Centers

Panel of Peers Discussion

The Clinical Trial
Imaging Accuracy Crisis

Breaking studies suggest there is an alarming level of inaccuracy in clinical trial imaging data across leading cancer centers. As all cancer centers face similar challenges, these consistent findings indicate a broader crisis at hand. Join the discussion as a panel of five AACI member cancer centers discuss their own discoveries and what they’re doing to ensure trial imaging data is accurate, compliant, and complete.

Listen to the full panel discussion on:

Error Rates &
Game-Changing Technology

After the implementation of Yunu, we went from 50% inaccurate measurements and we decreased it to 2%! For us, that was a game changer!

Dr. Arcadia Cruz
Associate Administrative Director
UCSD Moore's Cancer Center

Complete Compliance &
Audit Readiness

When you're looking at bringing a drug to market that's not just going to impact the patients that you have at your site, but patients potentially world-wide.

Kira Pavlik
Associate Director, Clinical Trials Operations
Yale Cancer Center

Collaborative Workflows &
On-Demand Resources

We're creating a platform that you can select anybody you want to have read and they can connect securely and you can invite them into your workflows.

Jeff Sorenson
Co-Founder & CEO
Yunu

Article | Clinical Trial Vanguard

Urgent Warning: Dangers and Costs
of Clinical Trial Imaging Errors

Read Article

Delivering a new standard for
clinical trial imaging data and workflow

With thousands of imaging clinical trials relying on the platform each day,

Yunu is serving life science companies and cancer centers to ignite collaboration and accelerate innovation.

Faster Results

Eliminate delays, accelerate results, and achieve a faster time-to-market for trials sponsors and CROs.

Better Care

Optimize trial outcomes for sponsors, principal investigators, study staff, and patients.

Greater Accuracy

Ensure precision measurements and tracking for radiologists, oncologists, and trial coordinators.

Simpler Workflow

Easier tools, task management, and audit readiness for clinical sites.

Explore the Yunu Platform

Access & Diversity

In oncology, 90% of clinical trials require tumor measurements, but access and diversity issues arise because most trials occur at a few sites. Only 3% of patients from where 80% of the population receives care enroll in trials. To address this, a platform that allows data sharing and collaboration across sites and at the community level is essential."

Dr. Gordon Harris | Co-Dir. of the Tumor Imaging Metrics Core at Dana Farber / Harvard Cancer Center & Co-founder & CSO, Yunu

Collaboration

"We actually end up collaborating a great deal with the radiology department. And once we started looking at the data itself, we realized that more than 50% of all of our findings had some level of issues."

Dr. Arcadia Cruz | Associate Administrative Director UC San Diego Moores Cancer Center

Customer Support

The Yunu team has been incredibly supportive of every issue that we have. We have a really good team. So, it's almost like having an entire partnership that has changed our outcomes. We are meeting the endpoints for our protocols with specificity, efficiency, and reproducibility.

Dr. Arcadia Cruz | Associate Administrative Director UC San Diego Moores Cancer Center

Unlock imaging data. Unify multi-site trials.

Why choose Yunu?

Through the power of multi-organization workflows and true cloud-based collaboration, Yunu makes it possible to connect study teams, core labs, sponsors, CROs, and off-site clinical resources so that scaling your clinical trials operation does not distract from busy clinical routines.

4,200+

Clinical trials that extend to
over 8000 clinical sites

2,600+

Registered Yunu solution users
across all types of study staff

400+

Life sciences companies are lead sponsors of trials on Yunu

Schedule your demo today!

By the Numbers

Site-based imaging assessments suffer from high error rates and inconsistent adherence to protocols, jeopardizing trial integrity and patient outcomes. The Yunu Platform enhances site reads with advanced tools for precision and protocol compliance.